A method for modifying the pharmacokinetics of a pharmacologically active agent that undergoes direct N-glucuronidation by UDP-glucuronosyltransferase isoenzyme UGT2B10 in a human subject comprising administering an effective amount of an UGT2B10 modulator to said human subject. A method for identifying compounds which are directly metabolized by UGT2B10 or which act as UGT2B10 modulators is also disclosed.

 
Web www.patentalert.com

< Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels

> Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

> Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts
~ 00596